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ABSTRACT
Tumor necrosis factor (TNF) initiates local inflam-
mation by triggering endothelial cells (EC) to
express adhesion molecules for leukocytes such
as intercellular adhesion molecule-1 (ICAM-1 or
CD54). A prior study identified siRNA molecules
that reduce ICAM-1 expression in cultured human
umbilical vein EC (HUVEC). One of these, ISIS
121736, unexpectedly inhibits TNF-mediated
up-regulation of additional molecules on EC, includ-
ing E-selectin (CD62E), VCAM-1 (CD106) and HLA-
A,B,C. 736 siRNA transfection was not toxic for EC
nor was there any evidence of an interferon
response. 736 Transfection of EC blocked multiple
early TNF-related signaling events, including activa-
tion of NF-iB. IL-1 activation of these same path-
ways was not inhibited. A unifying explanation is
that 736 siRNA specifically reduced expression of
mRNA encoding tumor necrosis factor receptor 1
(TNFR1) as well as TNFR1 surface expression. A
sequence with high identity to the 736 antisense
strand (17 of 19 bases) is present within the 3’UTR of
human TNFR1 mRNA. An EGFP construct incorpor-
ating the 3’UTR of TNFR1 was silenced by 736 siRNA
and this effect was lost by mutagenesis of this
complementary sequence. Chemical modification
and mismatches within the sense strand of 736 also
inhibited silencing activity. In summary, an siRNA
molecule selected to target ICAM-1 through its
antisense strand exhibited broad anti-TNF activities.
We show that this off-target effect is mediated by
siRNA knockdown of TNFR1 via its sense strand.
This may be the first example in which the off-target
effect of an siRNA is actually responsible for the
anticipated effect by acting to reduce expression of
a protein (TNFR1) that normally regulates expres-
sion of the intended target (ICAM-1).
INTRODUCTION
RNA interference (RNAi) is an evolutionarily conserved,
regulatory pathway found in many diﬀerent organisms
including petunias (1), Nuerospora (2), Caenorhabditis
elegans (3), Drosophila (4) and mammalian cells (5).
Recent investigations have revealed that RNAi plays a
key role in heterochromatic silencing and organization
(6,7), maintenance of genetic stability (8) and protection
from viral pathogens (9). Long double-stranded RNA
(dsRNA), from regulatory transcription elements, trans-
poson intermediates, or replicating viral agents, can be
recognized and processed within the cell by Dicer, an
endogenous RNase III-like enzyme, into short (21–23nt)
interfering dsRNA (siRNA) (10–13). These siRNAs
associate with a group of cellular proteins to form the
RNA-induced silencing complex (RISC) which mediates
siRNA unwinding, exposure of the guide (antisense)
strand, and interaction with target mRNA transcripts in
a sequence-speciﬁc manner. Synthetically produced
siRNA function similarly in cultured mammalian cells to
silence expression of speciﬁc gene products (5). RNAi is
now widely and routinely used as an experimental tool
for transient gene knockdown, target discovery screens
and in vivo therapeutic applications (14). The fundamental
concern is no longer whether a gene can be silenced,
but rather if the functional consequences observed are
attributable to the gene being targeted. Recent reports
have chronicled the phenomena of oﬀ-target eﬀects
of RNAi that result when non-speciﬁc cellular eﬀects
are generated as an unintended side eﬀect of siRNA
treatment. These oﬀ-target siRNA eﬀects can lead to
misinterpretations of the consequences of gene knock-
down with the end result being the false assignment
of a particular gene function to a speciﬁc target gene.
The majority of oﬀ-target eﬀects can be grouped into four
categories: (i) siRNA-like, (ii) miRNA-like, (iii) immune
stimulatory (interferon-like) and (iv) global (toxic)
non-speciﬁc inhibition. SiRNA-like oﬀ-target eﬀects
encompass situations where partial siRNA nucleotide
identity with non-targeted cellular genes (15) can lead to
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of many unintended cellular proteins. MiRNA-like
eﬀects follow from siRNA species mimicking the activity
of microRNA (miRNA) which primarily block protein
translation by cognate recognition of short nucleotide
sequences within the 30UTR of target genes (16,17).
Translational block can lead to depressed cellular protein
levels without a corresponding drop in gene transcript
levels. As part of the innate immunity, mammalian cells
recognize dsRNA species, such as replicative viral inter-
mediates, and initiate an interferon stress response that
includes generalized RNA degradation and protein
synthesis inhibition (18). Recent ﬁndings have demon-
strated that certain 21nt siRNA are able to trigger the
interferon response (19). Using a functional genomics
approach, researchers found that many interferon-
stimulated genes (ISG) were activated in siRNA- but not
mock-transfected mammalian cells. Finally, some siRNAs
appear to initiate cell injury or death, and as part of this
response, cells may broadly shut down various biosyn-
thetic functions, including transcription and translation.
ISIS 121736 (736) is a double-stranded siRNA whose
antisense strand is complementary to a sequence within
the coding region of intercellular adhesion molecule-1
(ICAM-1, or CD54) and 736 transfection was shown
to reduce ICAM-1 expression in TNF-treated human
umbilical vein endothelial cells (HUVEC) (20). We ﬁnd
that 736 actually exhibits broad anti-TNF activities
through selective siRNA knockdown of the ICAM-1
regulator, TNFR1, via its sense strand and that the
unintended eﬀect on TNFR1 is more relevant than the
direct eﬀect on ICAM-1. While siRNA sense strand
oﬀ-target silencing activity has been suggested in previous
in vitro biochemical studies (21–23) and genome-wide
screens (15), our report is the ﬁrst example of an oﬀ-target
eﬀect in which the sense strand of an siRNA displays
an unintended eﬀect by silencing an ‘upstream’ regulator
of the intended target.
MATERIALS AND METHODS
Reagents
TNF and IL-1 were obtained from R&D Systems
(Minneapolis, MN, USA). Antibodies used are anti-p65
and anti-IkBa (Santa Cruz, Biotechnology, Inc., Santa
Cruz, CA, USA), anti-TNFR2 (Biosource; Camarillo,
CA, USA), anti-phospho SAPK/JNK, anti-phospho p38
(Cell Signaling Technologies; Beverly, MA, USA), and
anti-b-actin (Sigma; St Louis, MO, USA), anti-ICAM-
1-FITC, anti-E-selectin-FITC, anti-VCAM-PE, anti-
HLA-ABC-FITC (Immunotech; Miami, FL, USA),
anti-TNFR1-FITC, anti-AnnexinV-FITC, anti-TNFR1,
anti-RIP-1, anti-TRAF2, anti-TRADD (Pharmingen,
San Diego, CA, USA) and anti-ICAM-1 (R&D
Systems). Hoechst dye 33258 was from Molecular
Probes (Eugene, OR, USA). Unless otherwise speciﬁed,
all other reagents were from Sigma Chemical Co.
(St. Louis, MO, USA). Quantikine human soluble
TNFR1 ELISA (R&D Systems) was used to detect
sTNFR1 and was used according to the manufacturer’s
instructions.
Construction of mutantEGFP/TNFR1 3’UTR
retroviral constructs
The EGFP coding sequence was PCR ampliﬁed from
pEGFP-C1 (Clonetech, Mountain View, CA, USA) using
EGFP-speciﬁc primers with a 50-tailed BamHI site and
a3 0-tailed homology domain corresponding to the most
50 proximal sequence of the TNFR1 30UTR. The complete
TNFR1 30UTR was ampliﬁed from HUVEC cDNA using
TNFR1-speciﬁc primers. The two ampliﬁed products were
annealed, PCR ampliﬁed and inserted into pCR2.1 using a
TOPO TA Cloning Kit (Invitrogen). The EGFP/TNFR1
30UTR fragment was liberated by BamHI/NotI restriction
digest and sub-cloned into the multiple cloning site
of pLZRS. To generate EGFP/TNFR1 736 mutants,
a fragment containing the upstream EGFP/TNFR1
30UTR sequence and a mutant 736 sequence at the 30
end was generated by PCR. A second fragment bearing
the same 736 mutant sequence linked at the 50 end to the
downstream EGFP/TNFR 30UTR sequence was annealed
to the upstream fragment, PCR ampliﬁed and sub-cloned
into pLZRS. These constructs appear in Figure 6B.
Cells and cell culture
All human cell cultures were prepared under protocols
approved by the Yale Human Investigations Committee.
HUVEC were isolated and cultured as previously
described (24) and used at passage 2 or 3 in all experi-
ments. Cultures were uniformly positive for CD31 and
contained no detectable CD45
+ cells. In cells treated with
TNF, ICAM-1 and VCAM-1 were uniformly up-regulated
and over 90% expressed E-selectin. Human dermal
microvascular endothelial cells (HDMEC) supplied by
the Cell Culture Core of the Yale Skin Disease Research
Center were liberated from the superﬁcial vascular plexus
of the upper dermal layers of normal adult human skin
(provided as discarded surgical specimens) by dermatome,
by enzymatic digestion (50U/ml Dispase; Collaborative
Medical Products) for 30min at 378C, and then by ﬁne
mincing as described previously (25). Released cells were
cultured on 10mg/ml ﬁbronectin-coated plastic (Falcon,
Lincoln Park, NJ, USA) in EGM2-MV growth medium
(Cambrex, East Rutherford, NJ, USA). Between sub-
culture one and two, substrate-adherent cells were
resuspended for isolation on a mini-MACS column
by immunoselection using anti-CD-31-biotin followed by
streptavidin-magnetic beads (Miltenyi Biotec, Auburn,
CA, USA). In response to TNF, HDMEC uniformly
up-regulate ICAM-1 and VCAM-1 expression, and over
90% express E-selectin.
To produce EGFP/TNFR1 30UTR chimera-expressing
HUVEC cell lines, retroviral supernatants were produced
by transfecting Phoenix amphotropic packaging cells with
EGFP/TNFR1 30UTR retroviral constructs to generate
virus supernatants which were used for HUVEC transduc-
tion as described (26). To produce over-expressing
HDMEC cell lines, the cDNA for human ICAM-1 and
E-selectin were ligated into the retroviral vector pLZRS
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Cells were used between passages four and eight for the
experiments described.
siRNA transfection
HUVEC or HDMEC were plated onto gelatin-coated
12-well plates at  70% conﬂuence. At 24h post-plating,
mixtures of OligofectAmine (Invitrogen, Carlsbad, CA,
USA) to 20ml/ml and siRNA to 50 nM were prepared
in Opti-MEM I Reduced Serum Medium (Invitrogen) and
these concentrated mixtures of siRNA complexes were
diluted 5-fold to a 1X concentration before co-incubation
with EC cultures for 6h at 378C. Fresh medium was added
overnight and cells were re-transfected 24h later, rested
for 24h, and then treated with 10ng/ml human TNF
for 24h where indicated. SiRNA duplexes were obtained
from Dharmacon, Inc. (Lafayette, CO, USA):
736 (AS): 50GUGGCCUUCAGCAGGAGCUdTdT30
736 (S): 50AGCUCCUGCUGAAGGCCACdTdT30
lamin (AS): 50UGUUCUUCUGGAAGUCCAGdTdT30
lamin (S): 50CUGGACUUCCAGAAGAACAdTdT30
TNFR1-1 (AS): 50PGUACAAGUAGGUUCCUUUG
UU30
TNFR1-1 (S): 50CAAAGGAACCUACUUGUACUU30
TNFR1-2 (AS): 50PUAGUAGUUCCUUCAAGCUC
UU30
TNFR1-2 (S): 50GAGCUUGAAGGAACUACUAUU30
LFA-3 (S): 50CAGCCAUCGAGGACUUAUAdTdT30
LFA-3 (AS): 50UAUAAGUCCUCGAUGGCUGd
TdT30
The following single strand RNA oligos were purchased
from Dharmacon:
736 (AS): 50GUGGCCUUCAGCAGGAGCUdTdT30
736 (S): 50AGCUCCUGCUGAAGGCCACdTdT30
[also synthesized as 20-O-methyl modiﬁed versions of
736 (AS) and 736 (S)]
736 50deoxy (S): 50deoxy-AGCUCCUGCUGAAGG
CCACdTdT30
736/M4 (S): 50AGCGCCUGCUGAAGGCCACdTdT30
736/M6 (S): 50AGCUCAUGCUGAAGGCCACdTdT30
736/M16 (S): 50AGCUCCUGCUGAAGGACACdTdT30
736/M15/16 (S): 50AGCUCCUGCUGAAGUACACd
TdT30
736/Bulge (S): 50AGCUCCUGACUAAGGCCACdTdT30
Quantitative RT-PCR
Knockdown of siRNA-transfected, TNF-treated EC was
assessed by qRT-PCR 24h after the last transfection.
Total RNA was isolated using the RNeasy column system
(Qiagen, Valencia, CA, USA) and reverse transcribed with
the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA,
USA). For real-time qPCR, cDNA, MgCl2 and primers
were added to Platinum SYBR Green qPCR SuperMix
(Invitrogen). Samples were ampliﬁed for 35 cycles on a
iCycler thermocycler (Bio-Rad): 508C for 2min, 958C for
2min, 958C for 15s, 628C for 15s, 728C for 15s and 728C
for 5min. cDNA input levels for each sample were
normalized to levels of b-actin ampliﬁed with actin-
speciﬁc primers. Threshold cycles for each sample were
compared to control (mock-transfected) samples after
b-actin normalization. Primers used in qRT-PCR
reactions were:
b-actin Forward: 50ATGGGTCAGAAGGATTCCTA
AGTG30
b-actin Reverse: 50CTTCATGAGGTAGTCAGTCAG
GTC30
OAS1 Forward: 50TCAGAAGAGAAGCCAACGTGA30
OAS1 Reverse: 50CGGAGACAGCGAGGGTAAAT30
PKR Forward: 50GCCTTTTCATCCAAATGGAA
TTC30
PKR Reverse: 50GAAATCTGTTCTGGGCTCATG30
TNFR1 Forward: 50GCCAGGAGAAACAGAACACC30
TNFR1 Reverse: 50CTCAATCTGGGGTAGGCACA30
TNFR2 Forward: 50GCCAACATGCAAAAGTCTTCT
GTA30
TNFR2 Reverse: 50CAGGTGCAGATGCGGTTCTG
TT30
TRADD Forward: 50CACTCGGTGCCGCTGCAACT30
TRADD Reverse: 50TCAGATTTCGCAGCGCA
TCCT30
TRAF2 Forward: 50ACTGCTCCTTCTGCCTGGCCAG
CAT30
TRAF2 Reverse: 50CAGGTGCATCCATCACTGGGAC
AGA30
RIP-1 Forward: 50GGAGATTGGTGGGACGAGTT30
RIP-1 Reverse: 50TCCCAGATTTTCCCTGATTG30
EGFP Forward: 50CCTACGGCGTGCAGTGCTT
CAGC30
EGFP Reverse: 50CGGCGAGCTGCACGCTGCGTC
CTC30
FACS analysis
siRNA-transfected HUVEC expression of ICAM-1,
E-selectin, VCAM-1 and MHC class I were determined
by FACS analysis (FACSort, Becton Dickinson) after
immunostaining with saturating concentrations of directly
labeled antigen-speciﬁc or isotype-matched monoclonal
antibodies. To measure apoptosis, siRNA-transfected
HUVEC were collected and stained with FITC-labeled
anti-AnnexinV or isotype-matched antibodies for 30min
on ice. The same cells were stained with 5mg/ml propidium
iodide for 10min and analyzed for ﬂuorescence using the
BD FACSort.
Immunocytochemistry
To assess p65 translocation, siRNA-transfected HUVEC
monolayers were washed twice with PBS (1  PBS
containing Ca
++ and Mg
++) and ﬁxed for 30min. at
RT with 4% paraformaldehyde/PBS. Monolayers were
washed again with PBS and treated for 30min. with
staining buﬀer (0.5% BSA, 2mM EDTA in PBS)
containing 0.1% Triton X-100 and 0.5% donkey serum.
Rabbit anti-human-p65 antibody was added to HUVEC
Nucleic Acids Research, 2008, Vol. 36, No. 4 1083monolayers, and incubated at 48C overnight. Donkey
anti-rabbit IgG Alexa Fluor 488 (Molecular Probes) was
added and again incubated overnight.
Cellular growth curve
siRNA-transfected or mock-transfected EC were collected
and replated at 1000 cells/well in multiple gelatin
coated 96-well plates. At the indicated times, cell mono-
layers were washed with PBS, ﬁxed in ethanol and treated
with a ﬂuorescent nucleic acid stain, Hoechst
33258at 100mg/ml for 30min. Nucleic acid ﬂuorescence
(excitation=360nm and emission=460nm) was mon-
itored using a Cytoﬂuor I automated ﬂuorescence plate
reader at gain=80 and reported as relative ﬂuorescence
units (RFU).
Westernblot analysis
HUVEC were transfected with siRNA in gelatin-coated
12-well plates. Cells were treated with or without TNF or
IL-1 for various times and whole cell lysates were
prepared. Protein concentrations were determined using
BCA Protein Assay (Pierce, Rockford, IL, USA). Ten (10)
mg of each lysate was resolved using SDS-PAGE, proteins
were transferred to Immobilon-P PVDF (Millipore,
Bedford, MA, USA) and the membranes were blocked
in 5% non-fat milk (Bio-Rad, Hercules, CA, USA).
Antigen-speciﬁc antibodies and HRP-conjugated second-
ary antibody (Pierce) were used in conjunction with a
Femto SuperSignal chemiluminescent substrate (Pierce)
to detect target proteins.
RESULTS
736 Inhibits TNF-a-induced
_ effects on human endothelial
cells
In vitro screening of a panel of anti-ICAM siRNA mole-
cules performed by Vickers et al. (20) revealed an active
siRNA compound, ISIS 121736 (hereafter designated 736),
that was eﬀective at inhibiting TNF-mediated induction of
ICAM-1 on cultured HUVEC. We conducted a BLAST
search designed to identify non-targeted transcripts with
identity to 736 and found no perfect matches to 736 in the
RefSeq database. Human zinc ﬁnger protein 3 (Accession
#BC011887) displayed 17 contiguous homologous base
pairs with 736, but was unaﬀected by 736 transfection
(data not shown). In the course of our independent study
analyzing functional eﬀects of ICAM-1 expression on
human endothelial cells (EC), we conﬁrmed the activity of
736 identiﬁed in Vickers et al. (Figure 1). Speciﬁcally, we
found that TNF-induced ICAM-1 cell surface expression
was inhibited by 77% when compared to lamin siRNA-
transfected HUVEC using FACS analysis. However, tests
for siRNA speciﬁcity revealed that 736 transfection
unexpectedly inhibited a number of other TNF-inducible
cell surface proteins. E-selectin was inhibited by 71%,
VCAM-1 by 81% and MHC class I by 40% compared
to lamin siRNA-transfected HUVEC (Figure 1). Similar
results were observed for transfected HDMEC suggesting
that both EC types are similarly aﬀected by 736 activity
(data not shown). These results were surprising since none
of these TNF-responsive genes have signiﬁcant homology
with 736 and so we chose to investigate further the
mechanism of action of 736.
First, to determine whether the 736 oﬀ-target activity
was due to a general cytotoxic eﬀect we assessed the
activity of this siRNA on cell growth by plating 736
and lamin siRNA-transfected HDMEC into 96-well plates
and monitoring their growth rates using a Hoechst
ﬂuorescent dye assay. The growth rates of transfected cells
were compared to the growth of mock-transfected
(OligofectAmine alone) or lamin siRNA-transfected
HDMEC. All cells grew progressively and no diﬀerence
in growth rates among the three treated groups was
detected over a 7-day period (Figure 2A). To determine
whether 736 induced cell death, the levels of apoptosis
or necrosis in siRNA-transfected and control HUVEC
cultures was measured. Mock-transfected and 736 or
lamin siRNA-transfected HUVEC were harvested 24h
post-transfection and tested for AnnexinV staining or
propidium iodide (PI) exclusion by FACS analysis
(Figure 2B). AnnexinV staining was low in all three
groups and was not elevated in 736-transfected cells
compared to lamin siRNA-transfected cells. Although
some PI uptake was detected, there was no increase in PI
incorporation in 736 versus lamin siRNA-transfected cells.
An earlier sign of cell injury is activation of TNFa
converting enzyme (TACE) and subsequent shedding of
surface TNFR1, which could cause TNF unresponsive-
ness (27). To ascertain whether TNFR1 was present in the
media of transfected cells, an ELISA was used to detect
soluble or shed TNFR1 (sTNFR1) in mock- or siRNA-
transfected HUVEC conditioned media. Untreated
HUVEC cultures spontaneously shed 25–30pg/ml of
sTNFR1 over a 24-h period while cells treated for
15min with histamine, a known TACE activator (28),
increased the production level to 65pg/ml sTNFR1 over
the same time period (data not shown). HUVEC
transfections were performed for periods of 1, 4 and 48h
and culture media was collected after 24 additional hours
of undisturbed growth. Conditioned media from mock- or
lamin siRNA-transfected cells maintained similar levels
of sTNFR1 as the untreated HUVEC control cells
(25–30pg/ml) whether they were transfected for 1, 4 or
48h (Figure 2C). Cells transfected with 736 siRNA also
released similar levels of sTNFR1 ( 25pg/ml) when
transfected for 1 or 4h, and showed diminished levels
of sTNFR1 (5pg/ml) in the culture media after 48h of
transfection, ruling out an eﬀect due to receptor shedding.
Many double-stranded siRNA are detected by intra-
cellular proteins and can produce an interferon stress
response through the activation of cellular stress response
genes such as 20-50-oligoadenylate synthetase 1 (OAS1)
and protein kinase R (PKR). These genes can trigger
a wide array of cellular responses that could account
for the unique phenotype of 736 siRNA-transfected cells.
To rule out this possibility, gene-speciﬁc oligonucleotide
primers were designed to monitor the induction of OAS1
and PKR mRNA in siRNA-transfected cells using real-
time qPCR. PolyI:C, a potent stimulator of the interferon
1084 Nucleic Acids Research, 2008, Vol. 36, No. 4response, elicited a 2299-fold increase in OAS1 message,
but there was no induction of OAS1 observed in 736 or
lamin siRNA-transfected HUVEC compared to mock-
transfected controls (Figure 2D). PKR transcripts in Poly
I:C treated HUVEC increased by 12.4-fold while HUVEC
transfected with 736 or lamin siRNA showed no PKR
induction when compared to mock-transfected cells. These
analyses show that interferon response genes are not
induced by 736 and are unlikely to be responsible for the
observed 736 siRNA phenotype.
736 Inhibits TNF,but notIL-1 signaling
To further analyze the eﬀect of 736 on TNF-induced
proteins, we examined speciﬁc signal transduction path-
ways. NF-kB is a critical messenger for transducing
inﬂammatory signals in EC. The three surface antigens
we found to be negatively regulated by 736 transfection
are all up-regulated through NF-kB signaling. Therefore,
we examined if 736 transfection interfered with NF-kB
activation. We initially used p65 (RelA) nuclear transloca-
tion as a measure of NF-kB activation. HUVEC were
siRNA-transfected and rested for 24h. TNF was added
to the HUVEC cultures at varying concentrations and
incubated for 15min after which the cells were ﬁxed
and prepared for p65 (RelA) immunocytostaining.
p65 was diﬀusely localized within the cytoplasm of
HUVEC cells in cultures where TNF had been withheld,
but had markedly translocated and accumulated in the
nucleus of TNF-treated cells (Figure 3A). Lamin siRNA-
transfected cultures treated with TNF displayed a similar
pattern, with nearly all the p65 localized to the nucleus,
suggesting normal NF-kB activation. Some translocation
in 736- treated cells was detectable, but the number of
cells exhibiting nuclear staining and overall signal
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Figure 1. 736 Inhibits TNF-mediated HUVEC antigen expression. HUVEC were mock-transfected or transfected with 10 nM 736 or lamin siRNA
on consecutive days and treated with 10ng/ml TNF for 24h. HUVEC were immuno-stained using ﬂuorescent antigen-speciﬁc antibodies for
E-selectin, ICAM-1, VCAM-1 and MHC I and analyzed by ﬂow cytometry. Filled histograms represent antigen-speciﬁc staining and empty
histograms represent isotype control staining. Corrected MFI in the upper right hand corner=antigen-speciﬁc MFI minus isotype MFI.
Representative of one of three experiments with similar results.
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NF-kB inhibition, this assay is not easily quantiﬁable.
Therefore, we also measured degradation of IkBa by
immunoblotting. IkBa associates with NF-kB heterodi-
mers within the cytoplasm where it masks nuclear
localization signals (NLS). Proteolytic degradation of
IkB 
_ following pro-inﬂammatory cytokine treatment
(e.g. TNF and IL-1) leads to unmasking of NLS,
translocation and transactivation of NF-kB responsive
genes. To determine whether 736 inhibition of p65
translocation functioned at the level of IkBa degradation,
HUVEC cultures were siRNA transfected, treated with
TNF, and subjected to western blot analyses to gauge
the level of IkBa degradation. At the level of 0.1ng/ml
TNF, IkBa degradation was essentially complete in
mock- or lamin siRNA-transfected cultures, but 736
transfection prevented complete degradation of IkBa
(Figure 3B). These results indicate that TNF signaling is
intact in mock and lamin, but not in 736 siRNA-
transfected cells.
We then tested the speciﬁcity of the eﬀect on TNF
responses in EC. IL-1 shares many eﬀects on EC with
TNF, including ICAM-1 induction, but utilizes a distinct
receptor and assembles a diﬀerent early signaling complex.
While 736 was able to retard IkBa degradation in TNF
treated cells, we did not observe the same inhibitory eﬀect
in IL-1-treated cells (Figure 3B). At IL-1 doses that
resulted in complete IkBa degradation in mock- and lamin
siRNA-transfected cultures (0.1ng/ml), IkBa was also
completely degraded in 736 siRNA-transfected cells.
These data indicate that TNF receptor signaling and
IkB 
_ degradation is impaired in 736 siRNA-transfected
HUVEC, but signaling through IL-1 receptor remains
intact and is not aﬀected by 736 treatment. We also
examined IkBa proteolytic degradation in human dermal
ﬁbroblasts and, as in HUVEC, IkBa was completely
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Figure 2. 736 siRNA is not cytostatic or cytotoxic, and does not induce an interferon response. (A) siRNA-transfected or mock-transfected HDMEC
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ﬂuorescence plate reader and reported as relative ﬂuorescence units (RFU). (B) siRNA-transfected HUVEC were collected and stained with
AnnexinV-speciﬁc Ab or propidium iodide (PI). Fluorescence, indicating apoptosis or necrosis, was measured by ﬂow cytometry. (C) HUVEC were
siRNA transfected for 1, 4 or 48h. Culture supernatants were collected 24h after transfection and tested for soluble TNFR1 (sTNFR1), a measure of
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1086 Nucleic Acids Research, 2008, Vol. 36, No. 4degraded in TNF-treated cells transfected with lamin
siRNA, but was signiﬁcantly protected in 736 siRNA-
transfected cells (Figure 3C).
In addition to signaling through NF-kB, TNF and IL-1
also activate JNK and p38 MAPK. We examined the
ability of 736 to interfere with these pathways in a TNF-
speciﬁc manner. For this purpose, HUVEC were mock- or
siRNA-transfected then rested for 24h and treated with
either TNF or IL-1 for 20min. Cell lysates were resolved
by SDS-PAGE and immunoblotted using phospho-JNK
or phospho-p38 MAPK antibodies to detect activated
JNK or p38 MAPK, respectively. Little or no activated
JNK was detected in the absence of cytokine addition
(Figure 4A). Addition of IL-1 to mock-transfected or
siRNA-transfected cultures led to a signiﬁcant accumula-
tion of phospho-JNK. However, 736 transfection inhib-
ited the response to TNF so that cells treated with TNF
displayed signiﬁcant levels of phospho-JNK only in mock-
or lamin siRNA-transfected cells. In contrast to IL-1
treated cells, after simulation with TNF there was a
marked decrease in the level of activated SAPK/JNK
in 736 siRNA-transfected cultures. In addition, 736
siRNA-transfected cells were limited in their ability
to phosphorylate p38 MAPK following TNF treatment,
but not after IL-1 stimulation. Collectively, these data
suggest that 736 transfection reduces TNF signaling
in human EC and dermal ﬁbroblasts but does not
impair IL-1 signaling.
TNFR1 messageand protein levelsare reduced in
736-transfectedcells, butnot other TNF signalosome
components
To ascertain how long after siRNA exposure TNF
signaling defects were detectable, cells from siRNA-
transfected HUVEC were collected at 1, 4, 24 and 48h
after transfection. Lysates were immunoblotted for
phospho-JNK and phospho-p38 MAPK. SAPK/JNK
phosphorylation was only modestly reduced after 4h of
736 siRNA-transfection, but was almost entirely absent
at 24h after exposure to 736 and remained undetectable
up to 48h after transfection (Figure 4B). p38 MAPK
phosphorylation defects caused by 736 were slightly
slower to develop and less persistent than SAPK/JNK
defects. p38 MAPK phosphorylation was unaﬀected at
4h and was almost completely absent at 24h, but became
detectable again at 48h post-transfection. These data
suggest that 736 may aﬀect the expression of one or more
components of the TNF signaling apparatus. We then
measured the mRNA and protein levels of TNFR1 and
other TNF signalosome components. First, whole cell
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Figure 3. 736 Inhibits NFkB translocation and IkB-a degradation of
TNF-treated HUVEC. (A) Cells were transfected twice on consecutive
days with 736 or anti-lamin siRNA and treated with 10ng/ml TNF for
15min. Cultures were washed, ﬁxed in situ with paraformaldehyde, and
immunostained with a NF-kB p65-speciﬁc antibody. (B) HUVEC were
transfected twice on consecutive days with 736 or anti-lamin siRNA.
Cells were treated for 30min. with 0.01ng/ml TNF or IL-~ 1
_ Whole cell
lysates were prepared, resolved on SDS-PAGE, and immunoblotted
with an IkB- 
_-speciﬁc antibody. (C) Human ﬁbroblasts were siRNA
transfected and subsequently treated with TNF [0, 0.1, and 1.0ng/ml]
for 30min. Cell lysates were immuno-blotted with an IkB- 
_–speciﬁc
antibody. Representative of one of two experiments with similar results.
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Figure 4. JNK and p38 MAPK activity is suppressed in 736-treated
HUVEC. (A) HUVEC were transfected twice on consecutive days with
736 or lamin siRNA. Cells were treated for 30min. with TNF or IL-~ 1
_ whole cell lysates were prepared, resolved on SDS-PAGE and
immunoblotted with phospho-JNK and phospho-p38
__ -speciﬁc anti-
bodies. (B) Transfected HUVEC were TNF-treated (30min) at various
times after initial exposure to siRNA when lysates were collected
for SDS-PAGE and immunoblotting with phospho-JNK and phospho-
p38
__ -speciﬁc antibodies. Representative of one of two experiments with
similar results.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1087lysates from siRNA-transfected HUVEC were resolved
by SDS-PAGE and immunoblotted with antibodies
speciﬁc to ﬁve important signalosome members: TNFR1,
TNFR2, RIP-1, TRAF-2 and TRADD. TNFR1 protein
levels were substantially reduced when compared to mock-
or lamin siRNA-transfected HUVEC (Figure 5A). Other
signalosome components, including RIP-1, TRAF2 or
TRADD, were not aﬀected at the protein level by
736 siRNA-transfection. There was also no eﬀect on
TNFR2 protein levels.
Next, qRT-PCR analysis of transfected HUVEC
was performed to determine whether TNFR1 and other
signalosome component mRNA levels were aﬀected by
736 siRNA-transfection. RNA from transfected cells was
reverse transcribed and used as a template for a series
of qRT-PCR reactions with TNFR1, TNFR2, RIP-1,
TRAF-2 and TRADD gene-speciﬁc primers. The results
were normalized for cDNA input using b-actin speciﬁc
primers. 736 siRNA-transfected cells showed a substantial
reduction in TNFR1 mRNA compared to mock- or lamin
siRNA-transfected cells (Figure 5B). TNFR2, RIP1 and
TRAF2 mRNA levels were essentially unchanged across
all three transfected groups, while TRADD transcript
levels were modestly depressed in one of two experiments.
To test whether 736-mediated reduction of TNFR1 levels,
and not a direct eﬀect on ICAM-1, was responsible
for depressed ICAM-1 induction, we tested whether
736 would inhibit ICAM-1 levels if stimulated by
receptors other than TNFR1. We measured the levels
of ICAM-1 induction following TNF or IL-1 treatment
of 736-transfected HUVEC. As seen before, TNF-induced
ICAM-1 cell surface expression was reduced in
736-tranfected cells, but, in contrast, ICAM-1 levels
were only slightly aﬀected in IL-1 stimulated cells
(Figure 5C), indicating that 736 did not directly reduce
ICAM-1 levels. These data suggest that TNFR1, rather
than ICAM-1, is the principle target of 736 siRNA,
and explains its general inhibitory eﬀect on the TNF,
but not on the IL-1-induced inﬂammatory response.
Alignment of siRNA 736 with human TNFR1
Following our determination that 736 transfection-
reduced TNFRI protein and transcript levels, we
performed an alignment analysis (LALIGN: www.ch.
embnet.org) on both strands of 736 siRNA and human
TNFR1 mRNA (Accession number BC010140). We
found 17 of 19nt homology between the sense strand of
736 (736/sense) and TNFR1 mRNA at a position within
the 30UTR of TNFR1 that is 6nt downstream of the
polyA site (nt 2083–2101; Figure 6A). Mismatches at
position 7 and position 18 of the sense strand, neither of
which were G:U wobble mismatches, left two homologous
strings of 6 and 10 bases. No other homologies of >10nt
were found for 736 and TNFR1 mRNA. Based on this
observation, we hypothesized that 736/sense might target
the homologous sequence within the 30UTR of TNFR1
and cause TNFR1 knockdown via an siRNA mechanism.
To test this idea, we constructed three separate EGFP-
based chimeric transgenes (Figure 6B). In each case,
the coding sequence for EGFP was linked to the 30 UTR
of TNFR1 using recombinant PCR techniques. Each
of the three chimeric transcripts had a unique 19-base
pair sequence at the putative 736 target site. EGFP/
TNFR1-30UTR bears the wild-type 736 target site derived
from the 30UTR of TNFR1 (17 of 19nt homology),
EGFP/Scramble contains a scrambled version of the 736
target site (2 of 19nt homology) and EGFP/736AS has
a perfect homology (19 of 19nt) with the sense strand
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Figure 5. 736 siRNA selectively targets TNFR1 mRNA and protein
and selectively inhibits TNF responses. (A) HUVEC were mock-
transfected or transfected with 736 or lamin siRNA. Cell lysates were
prepared 24h after the last transfection, resolved by SDS-PAGE, and
immunoblotted with antibodies speciﬁc for TNF receptor signaling
proteins. (B) HUVEC were transfected with 736 or lamin siRNA.
cDNA from each culture was analyzed by qRT-PCR using TNF
signalosome-speciﬁc primers. Values were normalized using actin
controls and converted to ‘% mRNA Remaining’ relative to mock
expression levels. Representative of one of two experiments with similar
results. (C) HUVEC were transfected with 736 or lamin siRNA. Cells
were then stimulated for 24h with either TNF (10ng/ml) or IL-1b
(50ng/ml), immuno-stained using ﬂuorescent antigen-speciﬁc antibody
for ICAM-1 and analyzed by ﬂow cytometry.
1088 Nucleic Acids Research, 2008, Vol. 36, No. 4of 736. Each of these three chimeric transcripts were
inserted into the retrovirus, pLZRS, and used to produce
retroviral vectors capable of expressing the chimeric
transcripts in human EC. After being transduced with
each of these viral vectors, HUVEC that uniformly
expressed each chimeric transcript were prepared by
sterile FACS sorting based on their EGFP expression.
The three chimeric EGFP cell lines were siRNA-
transfected using our standard protocol, and EGFP
transcript expression was analyzed by qRT-PCR using
EGFP gene-speciﬁc primers. In addition, we analyzed
EGFP reporter protein expression by FACS. In cells
expressing EGFP/TNFR1-30UTR, mock- and lamin
siRNA-transfected cells showed no EGFP knockdown,
while 736 siRNA-transfected cells showed a >50%
knockdown compared to mock-transfected cells
(Figure 7A). EGFP/736AS HUVEC cells were unaﬀected
by mock or lamin siRNA transfection, but were sensitive
to 736 activity when compared to mock-transfected cells.
In contrast, 736 was not able to knockdown
EGFP/Scramble transcript levels. EGFP reporter protein
levels mirrored EGFP transcript levels in siRNA-trans-
fected cells. EGFP/TNFR1-30UTR and EGFP/736AS
cells expressed lower levels of EGFP reporter protein
when transfected with 736 siRNA as compared to mock-
and lamin siRNA-transfected cells and EGFP expression
in EGFP/Scramble cells was unaﬀected by 736 siRNA
(Figure 7B). Lamin siRNA knockdown of lamin tran-
scripts was conﬁrmed in all experiments (data not shown).
These results support the conclusion that an intact 19nt
TNFR1 30UTR target sequence is necessary and suﬃcient
for the observed 736 eﬀects on TNFR1 expression that
are most consistent with an siRNA mechanism.
736Sense strand activity isinhibited by chemical
andsequence modification
In our chimeric EGFP transcript studies, we were able
to establish the critical importance of the TNFR1 30UTR
target sequence for 736-mediated TNFR1 silencing.
To determine whether other anti-TNFR1 siRNA, target-
ing alternative transcript regions, produce a similar
TNFR1 3’UTR EGFP
EGFP/TNFR1 3′UTR:
3′UTR 5′UTR ORF
Wt TNFR1 Target Sequence
(17 of 19 bp Homology w/ 736)
EGFP/Scramble:
3′UTR 5′UTR ORF
‘Scrambled’ Target Sequence
(2 of 19 bp Homology w/ 736)
TNFR1 Target
Sequence
EGFP/736AS:
3′UTR 5′UTR ORF
736 antisense Target Sequence
(19 of 19 bp Homology w/ 736)
B
nt2083                 nt2101
TNFR1 mRNA                5’GGGGCCTTCAGCTGGAGCT3’
: :::::::::: ::::::
736 siRNA (Sense)     3’dTdTCACCGGAAGUCGUCCUCGA5’
18 7
A
Figure 6. 736 Sequence homology and location with TNFR1. (A) Base pair homology comparison of 736 siRNA sense strand with TNFR1 mRNA.
(B) Chimeric EGFP constructs indicating the location of the 736 target sequences and extent of sequence homology with 736.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1089functional phenotype as 736 we purchased two commer-
cially available siRNA reagents, TNFR1-1 and TNFR1-2.
We tested 736, TNFR1-1 and TNFR1-2 for functional
activity by their ability to inhibit TNF-mediated induction
of EC cell surface antigens. TNF-mediated expression of
E-selectin, ICAM-1 and MHCI were decreased 29, 51 and
30%, respectively, by 736 siRNA transfection compared
to lamin controls (Table 1). TNFR1-1 and TNFR1-2
siRNA transfection produced a similar, but more
pronounced decrease in antigen induction. TNFR1-1
inhibited E-selectin, ICAM-1 and MHC I by 70, 75 and
43%, respectively, and TNFR1-2 by 70, 78 and 58%,
respectively. This demonstrates that 736 displays a similar
functional eﬀect as other TNFR1 silencing siRNA.
Chemical modiﬁcation of RNA oligos can have
signiﬁcant consequences for siRNA activity and can be
used to identify strand utilization of an siRNA duplex.
We have used two chemical modiﬁcation strategies to
determine the role that the sense strand of 736 plays
in TNFR1 knockdown. First, we exploited the fact that
50 phosphorylation of the guide, or targeting, strand is
required for eﬃcient siRNA activity. Therefore, capping
the sense strand of 736 with a terminal 50 modiﬁcation that
inhibits phosphorylation should result in the inactivation
of 736 siRNA. We have prepared a hybrid 736 siRNA
with an unmodiﬁed antisense strand and a 50deoxy cap
on the sense strand [736(50Cap)]. We compared the
activity of this duplex with wild-type 736 by transfecting
HUVEC and measuring E-selectin and ICAM-1 induction
following TNF treatment (Figure 8). 736 inhibited
E-selectin by 62% and ICAM-1 expression by 55%
compared to lamin controls, while 736(50Cap) actually
showed increased E-selectin expression while only inhibit-
ing ICAM-1 by 15%. Next we used limited 20-O-methyl
modiﬁcation of RNA, which is known to inhibit siRNA
strand activity (29), to determine the strand utilization for
736. Speciﬁcally, we introduced 20-O-methyl modiﬁcations
at the 50 end (positions 1 and 2) of the sense or antisense
strands of 736 and prepared chemically modiﬁed, hybrid
siRNA duplexes (Figure 9A). HUVEC were transfected
with wild-type or modiﬁed siRNAs and tested for TNFR1
expression by immunoblotting (Figure 9B) and for
TNF-inducible protein expression by FACS (Figure 9C).
A control siRNA, LFA-3, had no eﬀect on TNFR1
protein expression. Transfection with unmodiﬁed, wild-
type 736 siRNA (736/WT) resulted in a pronounced
decrease in TNFR1. 20-O-methylation of the antisense
strand when paired with unmodiﬁed sense strand (736/AS)
largely preserved this siRNA eﬀect whereas modiﬁcation
of the sense strand, alone (736/S) or in combination
with modiﬁcation of the anti-sense strand (736/S+AS),
inhibited protein knockdown. Similarly 20-O-methylation
of the antisense strand (736/AS) alone produced a marked
reduction of ICAM and E-selectin, comparable to the
eﬀect of transfection with 736/WT. This result conﬁrms
that the unmodiﬁed sense strand is suﬃcient to produce
the anti-TNFR1 eﬀects of 736. When the sense strand
of 736 was modiﬁed (736/S) we did observe a modest
reduction in ICAM protein expression, but there was
no eﬀect on E-selectin. A direct but modest anti-ICAM
activity of the unmodiﬁed 736 antisense strand is likely
to be responsible for this result. These data support the
assertion that an unmodiﬁed, phosphorylated 736 sense
strand can be utilized to promote RNAi activity and
is both necessary and suﬃcient for eﬀective TNFR1
knockdown.
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Figure 7. TNFR1 30UTR Target sequence determines oﬀ-target activity
of the sense strand of 736. EGFP/TNFR1 30UTR chimeric constructs
were designed to contain wild-type TNFR1, or scrambled or ‘complete’
homology to the sense strand of 736. These constructs were inserted
into retroviral vectors and used to produce HUVEC cell lines which
express the target sequences. Transduced cell lines were transfected on
back to back days with 736 or lamin siRNA or with Oligofectamine
alone (mock). (A) qRT-PCR was performed on cDNA from each
culture using EGFP-speciﬁc primers. Values were normalized using
actin controls and converted to ‘% mRNA Remaining’ relative to
mock treatment. Representative of one of two independent experiments
with similar results. (B) Cells were collected 24h after the last
transfection and analyzed for EGFP reporter expression by ﬂow
cytometry. Corrected MFIs were converted to ‘% GFP Remaining’
relative to mock treatment. Two independent experiments are
represented.
Table 1. Comparison of 736 with other TNFR1 siRNA species
siRNA E-selectin ICAM-1
(MFI)
MHC I
Mock 72 892 242
Lamin 70 1058 224
736 50 522 155
TNFR1-1 21 267 127
TNFR1-2 21 232 94
HUVEC were transfected with indicated siRNA. Cells were treated
with TNF for 24h immunostained with E-selectin, ICAM-1 and
MHCI, and analyzed by ﬂow cytometry.
1090 Nucleic Acids Research, 2008, Vol. 36, No. 4These experiments cumulatively show that the sense
strand of 736 is capable of mediating TNFR1 knockdown
without full complementarity with its target sequence.
A question arises whether 736 is functioning as an
attenuated (mismatched) siRNA or as miRNA. SiRNA
activity is usually dependent on thermodynamic stability
throughout the target sequence, while miRNA activity is
critically dependent on nucleotides 2–8at the 50 end of the
strand. This so-called ‘seed’ region is extremely sensitive
to mismatches while the remaining portion of the
sequence may, or may not, participate in a compensatory
role to stabilize the miRNA-target duplex (30).
To clarify the sequence-dependent activity of the 736
sense strand, we prepared a series of siRNA duplexes with
an unaltered antisense strand paired to variously mutated
736 sense strands (see Table 2 for sequences). Using these
hybrid siRNA, we were able to compare 736 sequence-
dependent activity for sense strands bearing 0, 2, 3, 4
and 5nt mismatches with the TNFR1 target sequence.
In Table 2, we show that the introduction of mismatches
that destabilize duplex formation and increase free energy
of hybridization with the TNFR1 target sequence is
inversely related to a reduction in TNFR1 cell surface
expression and TNF-mediated induction of ICAM.
Notably, single mutations in the 736 sense strand were
inhibitory whether they were introduced within the poten-
tial miRNA ‘seed’ region (see 736/M4 and 736/M6)
or whether they were more proximal to the 30 region.
In addition, we engineered a 736 sense strand with an
intact potential 8nt 50 ‘seed’ region and a 3-nt canonical
bulge at positions 9–11 (Table 3). When duplexed with
ICAM-1 E-selectin
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736 (5′Cap)
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187 1160
Figure 8. 50 phosphorylation of the 736 sense strand is required for
eﬀective TNFR1 knockdown. Hybrid 736 siRNA duplexes were
prepared by annealing wild-type 736 antisense RNA oligos with
either wild-type 736 sense strand oligos [736 (WT)] or 50deoxy capped
736 sense strand oligos [736 (50Cap)]. HUVEC were mock-transfected
or transfected with 10 nM lamin, 736 (WT), or 736 (50Cap) siRNA on
consecutive days and treated with 10ng/ml TNF for 24h. HUVEC
were immuno-stained using ﬂuorescent antigen-speciﬁc antibodies for
E-selectin and ICAM-1 and analyzed by ﬂow cytometry. Filled
histograms represent antigen-speciﬁc staining and empty histograms
represent isotype control staining. Corrected MFI in the upper right
hand corner=antigen-speciﬁc MFI minus isotype MFI. Representative
of one of two experiments with similar results.
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Figure 9. 20-O-methyl modiﬁcation of the 736 sense strand eliminates
TNFR1 knockdown. (A) Hybrid 736 siRNA duplexes were prepared
by annealing unmodiﬁed 736 RNA oligos (sense or antisense) with
complementary RNA oligos modiﬁed by 20-O-methylation, (such
hybrid duplexes are indicated as 736/S or 736/AS). Dual modiﬁed
duplexes (736/S+AS) and wild-type 736 (736/WT) were also prepared.
20-O-Me modiﬁed bases are in bold and underlined. (B) HUVEC were
mock-transfected or transfected with 10 nM LFA-3, an irrelevant
siRNA, 736/WT, 736/S, 736/AS or 736/S+AS siRNA on consecutive
days and treated with 10ng/ml TNF for 24h. HUVEC were immuno-
stained using ﬂuorescent antigen-speciﬁc antibodies for ICAM-1 and
E-selectin and analyzed by ﬂow cytometry. Corrected MFIs were
converted to ‘% Remaining’ relative to mock expression. (C) Hybrid
siRNA-transfected HUVEC lysates were analyzed by western blot for
the expression of TNFR1 and b-actin. Representative of one of two
experiments with similar results.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1091the wt antisense 736 strand, this siRNA, having ﬁve
mismatches and a greatly lowered thermodynamic
stability with the TNFR1 target, exhibited a loss of
activity similar to other mutated strands, including
a 4-nt mismatched strand, 736/M15/16 (Table 3). Taken
together, these observations support a sequence-
dependent requirement for 736 activity by an siRNA
mechanism. An miRNA mechanism for TNFR1 silencing
in this system seems unlikely based upon our mutagenesis
studies and the eﬀect on TNFR1 mRNA and protein
levels.
TNFR1 complementarity withICAM-1 doesnot regulate
ICAM-1or TNFR1 expression
Natural antisense transcripts (NAT), like miRNA and
siRNA, are naturally occurring RNA species known to
negatively regulate gene function by inhibition of tran-
scription, RNA splicing and protein translation. In this
report, we have identiﬁed and characterized an siRNA
target sequence in the 30UTR of TNFR1 which has 18 of
20nt complementarity to a site within the coding sequence
of human ICAM-1 (an additional homologous base
pair between ICAM-1 and TNFR1 mRNA). Because of
this complementary sequence relationship, we investigated
whether TNFR1 transcript sequences might regulate
ICAM-1 mRNA levels by an NAT mechanism, or vice
versa. Because TNFR1 overexpression is toxic for EC
we used our EGFP chimera transduced cell lines, which
express steady state levels of EGFP/TNFR1 chimeric
mRNA. These cells were treated with graduated amounts
of TNF to induce ICAM-1 expression and cell surface
ICAM-1 levels were measured by FACS to determine
whether ICAM-1 levels were aﬀected by TNFR1
sequences. All three cell lines responded to TNF treatment
by up-regulating cell surface ICAM-1 levels.
EGFP/TNFR1-30UTR expressed slightly higher ICAM-1
levels than the other two lines (Figure 10A), and EFGP/
736AS cells had nearly identical ICAM-1 protein levels as
EGFP/Scramble. We conclude from this, and a similarly
conducted experiment, that ICAM-1 protein expression is
not negatively aﬀected by the presence of complementary
EGFP/TNFR1 chimeric mRNA sequences.
To further investigate the possibility of a natural
antisense regulatory relationship between ICAM-1 and
TNFR1, we tested whether HDMEC that stably express
high levels of ICAM-1 have lower levels of surface
TNFR1 expression. HDMEC from the same parental
line were transduced with an empty retroviral vector
(mock) or virus coding for ICAM-1 or E-selectin.
By FACS immunostaining, mock and E-selectin cell
lines expressed low basal ICAM-1 levels (MFI=21 and
18, respectively) while the ICAM-1 cell line expressed high
levels on their cell surface (MFI=5884; Figure 10B).
TNFR1 levels for mock and E-selectin HDMEC were
MFI 15.6 and 11.6, respectively, while ICAM-1 HDMEC
had a more profoundly reduced TNFR1 MFI of 7.7.
As a control, we also evaluated TNFR2 levels in these cell
lines and found the same expression pattern as TNFR1.
Mock and E-selectin lines had TNFR2 MFI of 26.4 and
25.2, respectively, and ICAM-1 HDMEC had a reduced
Table 2. 736 Sense strand knockdown activity is directly related to thermodynamic stability with TNFR1 target sequence
TNFR1 mRNA: 30 TCGAGGTCGACTTCCGGGGdTdT 50 ICAM (MFI) TNFR1 (MFI)  G (kcal/mol) Number of mismatches
TNFR1 50 AGCUCCAGCUGAAGGCCCCdTdT 30 187 5.2  26.8 0
736 50 AGCUCCUGCUGAAGGCCACdTdT 30 276 6.8  22.0 2
736/M4 50 AGCGCCUGCUGAAGGCCACdTdT 30 708 13.7  19.6 3
736/M6 50 AGCUCAUGCUGAAGGCCACdTdT 30 633 10.9  18.6 3
736/M16 50 AGCUCCUGCUGAAGGACACdTdT 30 817 11.6  18.2 3
736/M15/16 50 AGCUCCUGCUGAAGUACACdTdT 30 963 17.7  15.6 4
Lamin 986 21
Hybrid 736 siRNA duplexes were prepared by annealing wild-type 736 antisense RNA oligo with a TNFR1 mRNA complementary oligo (TNFR1),
wild-type 736 sense RNA oligo (736) and four other mismatched 736 sense strand oligos. Mismatches of the sense strand with the TNFR1 target
sequence are underlined and noted in the table. Free energy ( G) calculations were made with the help of the DINAMelt Web application
(www.bioinfo.rpi.edu).
HUVEC were transfected with hybrid siRNA containing wild-type 736 antisense oligo and mismatched 736 sense oligo or with lamin siRNA.
After transfection, cells were stimulated for 24h with TNF (10ng/ml) and immuno-stained for ICAM-1 and cells were immuno-stained with
TNFR1-speciﬁc antibody without TNF treatment.
Table 3. 736 Sense strand knockdown activity is not improved by incorporation of a bulge
TNFR1 mRNA: 30 TCGAGGTCGACTTCCGGGGdTdT 50 ICAM (MFI)  G (kcal/mol) Number of mismatches
736 50 AGCUCCUGCUGAAGGCCACdTdT 30 360  22.0 2
736/M15/16 50 AGCUCCUGCUGAAGUACACdTdT 30 906  15.6 4
736/Bulge 50 AGCUCCUGACUAAGGCCACdTdT 30 879  12.0 5
Lamin 1129
Hybrid 736 siRNA duplexes were prepared by annealing wild-type 736 antisense RNA oligo with wild-type 736 sense RNA oligo (736) and two
mismatched 736 sense strand oligos. HUVEC were transfected with indicated siRNA. Cells were treated with TNF for 24h immunostained with
ICAM-1-speciﬁc antibody, and analyzed by ﬂow cytometry. Mismatches of the sense strand with the TNFR1 target sequence are underlined and
noted in the table. Free energy (DG) calculations were made with the help of the DINAMelt Web application (www.bioinfo.rpi.edu).
1092 Nucleic Acids Research, 2008, Vol. 36, No. 4MFI of 15.3. A similar reduction of receptor expression
was observed in two additional independent sets of trans-
ductants. We conclude that ICAM-1 mRNA or protein
does appear to reduce TNFR1, but the eﬀect is not speciﬁc
and we cannot conclude that the complementary sequence
in TNFR1 or ICAM-1 act as endogenous natural
antisense agents.
DISCUSSION
The present study examines an unexpected oﬀ-target eﬀect
of an siRNA molecule, 736, previously identiﬁed in
a screen targeting ICAM-1(20). This study credited 736
for silencing TNF-stimulated ICAM-1 via an siRNA
mechanism. We independently conﬁrmed that 736 siRNA
eﬀectively silenced ICAM-1 expression in TNF-treated
EC, but found, unexpectedly, that ICAM-1 expression
induced by IL-1 was silenced much less eﬀectively
(Figure 5C). We interpret this to suggest that direct
targeting of ICAM-1 mRNA is not the primary cause of
736 inhibitory activity. Instead, the majority of ICAM-1
knockdown as well as the global oﬀ-target eﬀects of 736
on TNF-induced protein expression (E-selectin, VCAM-1
and MHC I) can be attributed to direct oﬀ-target silencing
of TNFR1 by the 736 siRNA sense strand. We demon-
strate this fact with three separate lines of investigation.
First, we show that with EGFP/TNFR1 chimeric trans-
cripts, bearing a wild-type 736 target site or a scrambled
736 target site, only transcripts with an intact target
sequence are sensitive to 736-mediated silencing
(Figure 7A and B). Next, we show that inhibition of 736
sense strand phosphorylation, which is known to aﬀect
RISC utilization, signiﬁcantly impedes the oﬀ-target
silencing of TNFR1 (Figure 8). In addition, we demon-
strate by 20-O-methyl chemical modiﬁcation of individual
siRNA strands that the 736 sense strand, and not the
antisense strand, is utilized to silence TNFR1 protein
expression and inhibit global TNF-mediated adhesion
molecule induction (Figure 9B and C). Both observations
strongly suggest that RISC strand utilization of the sense
strand is the primary mechanism of the observed oﬀ-target
eﬀect. And lastly, we prepared hybrid 736 siRNA duplexes
with the 736 antisense strand and sense strands containing
mismatches to the TNFR1 target (Tables 2 and 3).
Introducing one or more mismatches between the sense
strand and the target signiﬁcantly decreased silencing
activity in a duplex-stability and free energy dependent
manner. In addition, by correcting the two intrinsic
mismatches between 736 sense strand and TNFR1 we
improved duplex stability and siRNA silencing (Table 2).
Most RNAi silencing of oﬀ-target genes can be loosely
grouped into four general categories: immunostimulatory
or interferon-like, miRNA-like, siRNA-like or toxic.
We ﬁrst looked at the interferon response to determine
whether 736 was triggering a cellular stress response that
led to generalized RNA degradation and protein synthesis
inhibition. We do not believe that the oﬀ-target eﬀect
of 736 falls into this category because the levels of OAS1
and PKR mRNA were not increased in 736 siRNA-
transfected cells (Figure 2D). miRNA-like oﬀ-target
eﬀects, the reduction of protein levels in the absence of
mRNA knockdown, cannot account for the oﬀ-target
activity of 736 because TNFR1 mRNA is signiﬁcantly
reduced in 736-treated cells (Figure 5), suggesting an
siRNA-like degradation of TNFR1 transcript and
subsequent reduction of translational activity. We did
not conduct functional genomic expression proﬁling to
directly address the additional possibility that 736 siRNA
causes a transcriptome-wide eﬀect of gene knockdown
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Figure 10. Complementarity between TNFR1 and ICAM-1 does not
activate a natural antisense transcript (NAT) activity. (A) HUVEC cell
lines expressing EGFP/TNFR1 30UTR chimeric constructs were treated
for 24h with increasing concentrations of TNF to induce ICAM-1
expression. ICAM-1 expression levels were determined by FACS using
an ICAM-1-speciﬁc antibody. (B) HDMEC cell lines overexpressing
E-selectin and ICAM-1 were tested to determine basal TNFR1 cell
surface levels. Cells were immunostained with ﬂuorescently labeled
antibody speciﬁc for ICAM-1, TNFR1 and TNFR2 then analyzed
by FACS. Representative of one of two independent experiments with
similar results.
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through cell injury, but we did show that EC transfected
with 736 siRNA had similar growth rates, levels of
apoptosis, and levels of necrosis as control- or mock-
transfected cells (Figure 2). In addition, we can reasonably
attribute TNF signaling defects in 736 siRNA-transfected
EC speciﬁcally to the silencing of TNFR1 message since
protein and mRNA expression of other members of
the TNF signalosome (RIP-1, TRAF-2 and TRADD)
remain unchanged (Figure 5) and since IL-1 signaling
is unaﬀected in 736 siRNA-transfected cells (Figures 3B
and 4A). Based on our ﬁndings with chemical modiﬁca-
tions and sequence alterations as well as the observation
that mRNA reduction is suﬃcient to account for the
eﬀects on TNFR1 protein, we believe that an siRNA-like
eﬀect rather than an miRNA-like eﬀect can best account
for these data. Taken together, these observations support
the conclusion that the 736 oﬀ-target eﬀect is due to
TNFR1 mRNA knockdown by the sense strand via an
siRNA-like mechanism.
To our knowledge, the present study is the ﬁrst detailed
functional and mechanistic characterization of an RNAi
oﬀ-target eﬀect being mediated by an siRNA sense
strand that leads to the silencing of a protein (TNFR1)
that normally regulates expression of the intended target
(ICAM-1). Previous studies have suggested that sense
strands of siRNA are capable of entering the RISC
complex and participating in RNAi silencing (21,22).
In addition, Jackson et al. published a report showing that
oﬀ-target eﬀects can be mediated by a sense strand RNAi
mechanism (15). In a comprehensive functional genomic
expression screen, these authors used sequence compar-
ison of genes to identify siRNA oﬀ-target silencing
consistent with the sense strand of an siRNA, but these
important observations were not directly conﬁrmed by
mutagenesis studies. An important aspect of this work
is the unintended knockdown of an ‘upstream’ eﬀector
of the intended target. Other studies have reported
unintended knockdown of ‘downstream’ proteins in the
course of screening for ‘upstream’ eﬀectors. For example,
Lin et al. (23) used an siRNA library against protein
kinases in an eﬀort to identify ‘upstream’ eﬀectors of
Hif-1a protein stabilization and found, by directly
measuring Hif-1a levels, that several siRNAs in their
library directly targeted Hif-1a mRNA. However, there is
no evidence that the intended kinase targets are actually
upstream regulators of HIF-1a. In contrast, our study was
designed to target a ‘downstream’ protein, ICAM-1, and
lead to an unexpected silencing of an established
‘upstream’ regulator of the ICAM-1 pathway, TNFR1.
In this report, we have investigated the mechanism
by which 736 contributes to speciﬁc silencing of TNFR1
in some detail. Because 736 has incomplete homology
with TNFR1 and is targeting the 30UTR, both being
characteristic of miRNAs (31), it was necessary to ask
whether 736 uses a more siRNA-like or a more miRNA-
like mechanism to silence TNFR1. Recent reports have
indicated that siRNA species can silence mRNA expres-
sion in a similar fashion as miRNA (16) and that miRNA
can catalyze the enzymatic degradation of mRNA (32).
Promiscuous silencing mechanisms make it diﬃcult to
assign an siRNA or miRNA mechanism to 736 with
absolute certainty, but we favor a classical siRNA
mechanism based on the criteria of (i) eﬃcient mRNA
degradation, (ii) absence of a functional canonical
miRNA ‘seed’ region by mutational analysis, (iii) intact
cleavage site and (iv) thermodynamic duplex stability.
First, our data clearly show that TNFR1 mRNA is
reduced by the sense strand of 736, a prerequisite for
siRNA-like activity (Figure 5B). Degradation of mRNA
leads to protein loss (Figure 5A) and diminished
functional response to TNF (Figure 5C). miRNA silenc-
ing is dependent on target base recognition by a canonical
50 seed region within the miRNA strand (33) and nt 2–7
are most critical. But, the sense strand of 736 only has
a continuous string of 5bp identity at its 50 end with
TNFR1 in this region (Figure 6) making it a less than
optimum miRNA seed region candidate. The Lin et al.
(23) 7bp miRNA and Let-7 miRNA (34) both use a 7-nt
seed region for silencing, but we are unaware of smaller
sequence motifs that can mediate eﬃcient miRNA target
silencing. Furthermore, mutagenesis studies of functional
seed regions have shown that miRNA activity is pro-
foundly dependent on seed region duplex stability (30).
We tested whether the 50 region of the 736 sense strand
was suﬃcient to independently silence TNFR1 by
introducing mismatches in the 30 region of the 736 sense
strand (Table 2). The intact 50 region of 736 is signiﬁcantly
less active when a single mismatch is introduced at
position 16 from the 50 end (736/M16), and entirely
inactive when two mismatches are introduced outside the
seed region (736/M15/16). These data suggest that the 7nt
50 region of 736 sense strand is not suﬃcient to mediate
silencing. We also introduced mismatches into the 736
sense strand that would produce a siRNA:target bulge at
positions 9–11 (Table 3). Bulges spanning the ‘slicer’
endonuclease cleavage site are often present in miRNA
(31) and may serve to recruit additional components of the
miRNA machinery (35). With intact 50 and 30 736 sense
strand regions and a central canonical bulge (736/Bulge),
the modiﬁed 736 RNA produced diminished, not
enhanced, RNAi activity (Table 3). We reason from this
experiment that a bulge structure in 736 does not
positively enhance recruitment or activation of miRNA
components. We may also interpret these results as a loss
of siRNA function, demonstrating a strict requirement for
an intact, duplexed cleavage site for optimal 736 silencing
activity. Finally, we observe that any introduction of
siRNA:target mismatches inevitably destabilized the
duplex and lowered the free energy of hybridization
(Tables 2 and 3). It is widely acknowledged that
thermodynamic duplex stability greatly inﬂuences RNAi
activity, whether via an siRNA-like or miRNA-like
mechanism (30,36). Indeed, we observed that 736 knock-
down of TNFR1 is increased when the two intrinsic
mismatches between 736 sense and TNFR1 mRNA are
corrected (Table 2), supporting the notion that the sense
strand of 736 functions as an attenuated ‘classic’ siRNA.
Thus, 736 sense strand activity does not depend on
classical miRNA-like criteria, but the dominant factor
inﬂuencing 736 silencing activity appears to be the free
1094 Nucleic Acids Research, 2008, Vol. 36, No. 4energy and thermodynamic stability of the siRNA:target
duplex.
The complementarity of the transcripts encoding
ICAM-1 and TNFR1 raised the possibility that these
mRNA species could act as natural antisense transcripts
(NAT). NAT are recognized as an important mechanism
for transcriptional regulation in mammals (37) with recent
reports predicting the existence of NAT for 20% of
human mRNAs (38) and 72% of mouse mRNAs (39).
NAT are known to act at various stages including
inhibition of transcription, RNA splicing and protein
translation. NAT and cognate transcript duplexes can
serve as a substrate for Dicer leading to the destruction
of target transcript and generation of siRNA that would
further suppress gene expression (40). To detect a
potential antisense relationship between ICAM-1 and
TNFR1, we ﬁrst compared the levels of ICAM-1
expression in response to stimulation with known
amounts of TNF in our EGFP/TNFR1 transgene expres-
sing HUVEC. We found no diﬀerences in ICAM-1
induction whether the TNFR1 complementarity site
was present or absent. To test the converse relation-
ship, we determined whether elevated expression of
ICAM-1 in HDMEC cell lines could lower TNFR1
cell surface levels by triggering TNFR1 mRNA degrada-
tion in an antisense fashion. Here we did observe
a reduction of TNFR1 mRNA in ICAM-1 transduced
lines, but since TNFR2 was also depressed in these cells
(Figure 8) we were unable to conclude that TNFR1
transcript can negatively regulate ICAM-1, or vice versa.
Further study into the possible natural antisense relation-
ship between TNFR1 and ICAM-1 is warranted, but
more sensitive methodologies, including qRT-PCR and
in vitro RISC cleavage assays will likely be more
instructive.
Much recent eﬀort has been devoted to identifying
siRNA cross-reactivity at the design stage. Computational
database homology searches in silico can be used to
identify potential oﬀ-target eﬀects of prospective siRNAs
based on homology with non-targeted genes (41,42).
BLAST searches of candidate siRNAs will invariably
identify partial homologies with known mRNA
sequences (43). The question of whether to ‘disqualify’
prospective siRNAs based on sequence homology remains
controversial because no standard criteria exists today to
conﬁdently eliminate prospective siRNAs based on partial
homology with non-targeted genes. Early studies indicated
that single base pair mismatches between siRNA and
cognate target transcripts completely eliminated RNAi
activity (36). The current Editorial Policies of the Journal
of Biological Chemistry, based on the 2003 recommenda-
tions published in Nature Cell Biology (44), state that
a 1 or 2 base pair mismatch may be introduced as a
control to demonstrate siRNA speciﬁcity. More recent
investigations have revealed that RNAi activity is more
promiscuous than previously thought (45). Du et al.
systematically mutagenized a previously characterized
siRNA and found that siRNA complementarity require-
ments can be highly degenerative (46), and eﬃcient
silencing occurs even with 3 base pair mismatched
siRNAs (47). Moreover, even homology stretches as
short as 7nt have now been shown to mediate oﬀ-target
silencing (23). Indeed, we report here that the sense strand
of 736, having a 2-base pair mismatch, is capable of
signiﬁcant oﬀ-target knockdown of a TNFR1. Our study
provides experimental and functional evidence that
siRNAs with partial homology to non-targeted transcripts
can produce unexpected and misleading oﬀ-target eﬀects.
Developing highly reliable computational predictors
for oﬀ-target eﬀects will have signiﬁcant value in the
RNAi ﬁeld.
In the absence of clear computational standards,
oﬀ-target eﬀects caused by sequence similarities can be
managed by adhering to strict experimental target
validation protocols. Many excellent commentaries have
been published that outline guidelines for experimentally
validating siRNA speciﬁcity (48–50). Guidelines for
insuring siRNA speciﬁcity usually include the following
tenants; (i) monitor both mRNA and protein levels
of target genes to insure that protein levels agree with
observed loss-of-function phenotypes, (ii) rule out inter-
feron responses, (iii) identify the most eﬀective siRNAs
and titrate them to lowest eﬀective concentrations to limit
siRNA oﬀ-target and interferon responses, (iv) conﬁrm
loss-of-function phenotype with multiple siRNA’s to the
same target and (v) perform ‘rescue’ experiments with
siRNA-resistant target genes that fail to produce the
loss-of-function phenotype (44). An additional control
drawn from these data would be to monitor siRNA
eﬀects on non-target genes that are closely related to, or
activated similarly as the targeted transcript. For example,
the oﬀ-target eﬀects of 736 became apparent because we
measured E-selectin and VCAM-1 levels in our initial
siRNA screens, both of which are activated by TNF in
a similar manner as ICAM-1.
In summary, we have characterized an siRNA
compound composed of an antisense strand intended to
silence human ICAM-1 whose sense strand exhibited
an oﬀ-target eﬀect against TNFR1. We establish that
736-mediated knockdown of TNFR1 is not due to an
miRNA-like oﬀ-target mechanism or to an immuno-
stimulatory/interferon stress response, and we provide
experimental conﬁrmation that the sense strand of 736
functions as an siRNA leading to degradation of TNFR1
mRNA. This may be the ﬁrst example in which the oﬀ
target eﬀect of an siRNA is actually responsible for
the anticipated eﬀect by acting to reduce expression of
a protein (TNFR1) that normally regulates expression
of the intended target (ICAM-1).
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